Advancing Gynecologic Cancer Care, Research and Innovation
Story by:
Media contact:
Published Date
Story by:
Media contact:
Share This:
Article Content
At the University of California San Diego School of Medicine, research and education in the the Department of Obstetrics, Gynecology and Reproductive Sciences drive advances in the care and outcomes of patients with gynecologic cancers.
In recognition of Gynecologic Cancer Awareness Month, Michael McHale, MD, clinical professor and chief of the Division of Gynecologic Oncology at UC San Diego School of Medicine and obstetrician and gynecologist at UC San Diego Health, discusses the division’s approach to patient care, its research and clinical trials program, and what patients should know about gynecologic cancers.
What distinguishes the Division of Gynecologic Oncology?
Our gynecologic oncologists have extensive experience across the full spectrum of gynecologic malignancies, including ovarian, endometrial and cervical cancers, as well as less common cancers such as vulvar, vaginal and gestational trophoblastic disease. Our collective expertise encompasses complex surgical care, minimally invasive and robotic surgery, systemic therapy, clinical trial development, precision medicine and novel therapeutics.
This breadth allows us to approach each patient as an individual and develop treatment strategies tailored not only to their cancer, but also to their goals and circumstances.
Our academic and research mission is another major strength. As part of Moores Cancer Center at UC San Diego Health, we work in an environment where clinical care, laboratory science and clinical investigation are closely integrated. Our division has a robust clinical trials program, and our faculty participate in studies evaluating targeted therapies, immunotherapies, antibody-drug conjugates, molecularly directed treatments and innovative surgical approaches.
Most importantly, one of our strengths is the combination of experience and intellectual curiosity. Our physicians are not only treating patients with today’s therapies; they are actively asking what can be done better tomorrow.
How does the division approach caring for patients throughout the cancer journey?
Our approach is to care for patients throughout the entire cancer journey, from initial diagnosis and treatment through survivorship. Because gynecologic cancers can be complex, patients benefit from care coordinated by a team with deep expertise in cancer management and the unique medical, emotional and quality-of-life issues that accompany a cancer diagnosis.
Our gynecologic oncologists provide comprehensive surgical and medical management of gynecologic cancers, including surgery, chemotherapy, immunotherapy, targeted therapies and clinical trial participation when appropriate. We also work closely with colleagues in radiation oncology, pathology, radiology, genetics and other specialties to develop coordinated treatment plans.
Survivorship is an important part of gynecologic oncology care. So, our relationship with patients does not end when active treatment is completed, we continue monitoring for recurrence and addressing the effects of cancer and its treatment, such as menopausal symptoms, sexual health, bone health, emotional well-being, fatigue, fertility and reproductive concerns when relevant. Ultimately, treating a gynecologic cancer is about much more than treating a disease. It is about caring for a woman who has cancer.
What are some of the most exciting areas of research and innovation underway within the division?
We are in an exceptionally exciting period in gynecologic oncology research. The therapeutic landscape has evolved dramatically, with targeted therapies, immunotherapies, antibody-drug conjugates and other novel approaches providing patients with more treatment options.
Our research also extends beyond treatment. We are collaborating with colleagues in radiology and with translational scientists to develop better approaches to the early detection of ovarian cancer and to better understand toxicities associated with cancer therapies.
What makes this particularly exciting is the opportunity to translate innovation directly into patient care. We are not only treating patients with today’s therapies; we are actively studying what the next generation of therapies should look like. Our goal is to detect cancers earlier, develop more effective and less toxic treatments, and expand meaningful options for patients with recurrent or rare gynecologic cancers.
How does education and training contribute to the division’s clinical mission?
Education and training are fundamental to the mission of the division. We believe excellent patient care, education and research are interconnected.
Fellows, residents and medical students are integrated into our clinical environment and learn directly from experienced gynecologic oncologists across the full spectrum of gynecologic cancer care. Physicians and trainees are continuously exposed to the latest research, clinical trials, surgical techniques, emerging technologies and evolving standards of care.
The questions raised during teaching rounds, conferences, multidisciplinary discussions and in the operating room challenge our team to continually examine why we do what we do and whether there may be a better approach.
At UC San Diego Health, our patients are not simply being treated while we teach the next generation. They are benefiting from an environment where teaching, research and clinical care continuously make one another better.
How is the division working to promote health equity and improve access to specialized care?
Our division cares for patients at multiple locations throughout San Diego and the surrounding communities, allowing us to bring specialized expertise closer to where patients live while maintaining the resources and multidisciplinary support of an academic cancer center.
We recognize that access involves much more than having an appointment available. Patients can face barriers related to transportation, work and family responsibilities, finances, language, health literacy and navigating a complex health care system. Our care teams — including new patient navigators, nurses, advanced practice providers, social workers and clinical research staff — play an important role in identifying those barriers and helping patients navigate them.
Our commitment to health equity means striving to remove barriers rather than expecting patients to overcome those barriers on their own. Whether a patient comes to us from within San Diego or from a more distant community, our goal is to provide high-quality, compassionate, evidence-based gynecologic cancer care and ensure that every patient has the opportunity to benefit from the expertise, resources and innovations available at UC San Diego Health.
What should patients know about gynecologic cancers and when to seek specialized care?
The most important message is that gynecologic cancers can present with symptoms that are easy to overlook or attribute to other conditions. The five major gynecologic cancers —ovarian, uterine/endometrial, cervical, vulvar and vaginal — have different risk factors, warning signs and approaches to treatment.
Patients should talk with their health care provider about persistent or unusual symptoms, such as abnormal vaginal bleeding, bleeding after menopause, persistent pelvic or abdominal pain or pressure, unexplained bloating, changes in bowel or bladder habits, abnormal vaginal discharge, or persistent vulvar changes such as a lesion, itching or pain. These symptoms do not necessarily mean cancer, but if they are persistent, unexplained or different from what is normal for you, they should be evaluated.
Cervical cancer screening and HPV vaccination also remain important tools for prevention and early detection.
Awareness is not about being afraid of cancer — it is about being informed and proactive. If something changes and does not seem right, talk with your health care provider. When cancer is suspected or diagnosed, involving a gynecologic oncologist early can help ensure that patients receive specialized expertise and comprehensive care.
Our message is simple: know the warning signs, stay current with recommended screening and prevention, do not ignore persistent symptoms, and seek specialized care when cancer is suspected.
Read more news about: School of Medicine
Share This:
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.